| PRECLINICAL | evidence | ROS-responsive hydrogel coating modified titanium promotes vascularization and osteointegration of bone defects by orchestrating immunomodulation. | Tbeta4 | — | 2022-08-01 |
| PRECLINICAL | evidence | Fabrication of Tbeta4-Exosome-releasing artificial stem cells for myocardial infarction therapy by improving coronary collateralization. | Tbeta4 | — | 2022-08-01 |
| PRECLINICAL | evidence | Platelets and osteoblasts: secretome connections. | Thymosin β4 | — | 2022-08-01 |
| PRECLINICAL | evidence | Systemic gene therapy with thymosin beta4 alleviates glomerular injury in mice. | TB4 | Kidney function | 2022-07-16 |
| PRECLINICAL | evidence | Systemic gene therapy with thymosin beta4 alleviates glomerular injury in mice. | Thymosin beta 4 | — | 2022-07-16 |
| PRECLINICAL | evidence | Photorhabdus luminescens TccC3 Toxin Targets the Dynamic Population of F-Actin and Impairs Cell Cortex Integrity. | Thymosin β4 | — | 2022-06-24 |
| PRECLINICAL | evidence | Antimicrobial Peptides (AMPs) in the Pathogenesis of Alzheimer's Disease: Implications for Diagnosis and Treatment. | Thymosin β4 | — | 2022-05-28 |
| PRECLINICAL | evidence | Recombinant Human Thymosin beta4 (rhTbeta4) Modulates the Anti-Inflammatory Responses to Alleviate Benzalkonium Chloride (BAC)-Induced Dry Eye Disease. | Thymosin beta 4 | Inflammation | 2022-05-13 |
| PRECLINICAL | evidence | The role of fetal programming in human carcinogenesis - May the Barker hypothesis explain interindividual variability in susceptibility to cancer insurgence and progression? | Thymosin beta 4 | — | 2022-05-01 |
| PRECLINICAL | evidence | [Research advances on thymosin beta4 in promoting wound healing]. | Thymosin beta 4 | Wound healing | 2022-04-20 |
| PRECLINICAL | evidence | Can thymosin beta4 and soluble CD163 be used as biomarkers of the prognosis in acute on chronic liver failure? | Thymosin beta 4 | — | 2022-03-20 |
| PRECLINICAL | evidence | Pediatric Brain Tumors: Signatures from the Intact Proteome. | Thymosin β4 | — | 2022-03-16 |
| PRECLINICAL | evidence | Plasma proteome profiling using tandem mass tag labeling technology reveals potential biomarkers for Parkinson's disease: a preliminary study. | Thymosin beta 4 | — | 2022-03-01 |
| PRECLINICAL | evidence | Thymosin beta4 Suppresses LPS-Induced Murine Lung Fibrosis by Attenuating Oxidative Injury and Alleviating Inflammation. | Tbeta4 | — | 2022-02-01 |
| PRECLINICAL | evidence | Epicardial slices: an innovative 3D organotypic model to study epicardial cell physiology and activation. | Thymosin β4 | — | 2022-01-17 |
| PRECLINICAL | evidence | Thymosin beta-4 improves endothelial function and reparative potency of diabetic endothelial cells differentiated from patient induced pluripotent stem cells. | Thymosin beta 4 | — | 2022-01-10 |
| PRECLINICAL | evidence | Thymosin beta4 Is an Endogenous Iron Chelator and Molecular Switcher of Ferroptosis. | Tbeta4 | — | 2022-01-04 |
| PRECLINICAL | evidence | A novel proteomic-based screening method for ovarian cancer using cervicovaginal fluids: A window into the abdomen. | Thymosin β4 | — | 2022-01-01 |
| PRECLINICAL | evidence | Regulation of Chemosensitivity in Human Medulloblastoma Cells by p53 and the PI3 Kinase Signaling Pathway. | Tbeta4 | — | 2022-01-01 |
| PRECLINICAL | evidence | Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging. | Thymosin β4 | — | 2022-01-01 |
| PRECLINICAL | evidence | An Overview on Functional and Structural Properties of Monomeric and Multimeric beta-Thymosin in Invertebrates. | Tbeta4 | Wound healing | 2022-01-01 |
| PRECLINICAL | evidence | Effects of Thymosin beta4 on Myocardial Apoptosis in Burned Rats. | Tbeta4 | Wound healing | 2022-01-01 |
| PRECLINICAL | evidence | Remote ischemic preconditioning enhances aerobic performance by accelerating regional oxygenation and improving cardiac function during acute hypobaric hypoxia exposure. | Tbeta4 | — | 2022-01-01 |
| PRECLINICAL | evidence | In-silico Screening of Phytoconstituents on Wound Healing Targets - Approaches and Current Status. | Tbeta4 | Wound healing | 2022-01-01 |
| PRECLINICAL | evidence | Circular RNA PIP5K1A (circPIP5K1A) accelerates endometriosis progression by regulating the miR-153-3p/Thymosin Beta-4 X-Linked (TMSB4X) pathway. | Thymosin beta 4 | — | 2021-12-01 |
| PRECLINICAL | evidence | Thymosin beta4 and beta10 are highly expressed at the deep infiltrative margins of colorectal cancer - A mass spectrometry analysis. | Tbeta4 | — | 2021-12-01 |
| PRECLINICAL | evidence | Tbeta4 ameliorates oxidative damage and apoptosis through ERK/MAPK and 5-HT1A signaling pathway in Abeta insulted SH-SY5Y cells. | Tbeta4 | — | 2021-11-25 |
| PRECLINICAL | evidence | Discovery of thymosin beta4 as a human exerkine and growth factor. | Thymosin beta 4 | Glycemic control | 2021-11-01 |
| PRECLINICAL | evidence | Fetal programming of atherosclerosis: may the barker hypothesis explain the susceptibility of a subset of patients to develop stroke or cardiac infarct? | Thymosin beta 4 | — | 2021-11-01 |
| PRECLINICAL | evidence | Thymosin beta 4 alleviates non-alcoholic fatty liver by inhibiting ferroptosis via up-regulation of GPX4. | Tbeta4 | Liver health | 2021-10-05 |
| PRECLINICAL | evidence | In vivo CRISPR-Cas9 knockout screening using quantitative PCR identifies thymosin beta-4 X-linked that promotes diffuse-type gastric cancer metastasis. | Thymosin beta 4 | — | 2021-09-01 |
| PRECLINICAL | evidence | Recombinant human thymosin beta-4 (rhTbeta4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis. | Thymosin beta 4 | — | 2021-09-01 |
| PRECLINICAL | evidence | Effects of thymosin beta4-derived peptides on migration and invasion of ovarian cancer cells. | Tbeta4 | preclinical | 2021-08-01 |
| PRECLINICAL | evidence | Furan warheads for covalent trapping of weak protein-protein interactions: cross-linking of thymosin beta4 to actin. | Tbeta4 | — | 2021-06-21 |
| PRECLINICAL | evidence | Progress of esophageal stricture prevention after endoscopic submucosal dissection by regenerative medicine and tissue engineering. | Tbeta4 | — | 2021-06-01 |
| PRECLINICAL | evidence | Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State-New Directions in Anti-Aging Regenerative Therapies. | Thymosin beta 4 | Longevity & cellular aging | 2021-05-28 |
| PRECLINICAL | evidence | In Vitro-Evolved Peptides Bind Monomeric Actin and Mimic Actin-Binding Protein Thymosin-beta4. | Thymosin beta 4 | preclinical | 2021-05-21 |
| PRECLINICAL | evidence | Protein-Protein Connections-Oligomer, Amyloid and Protein Complex-By Wide Line (1)H NMR. | Thymosin beta 4 | — | 2021-05-18 |
| PRECLINICAL | evidence | Changes in Biomechanical Properties of A375 Cells Due to the Silencing of TMSB4X Expression Are Not Directly Correlated with Alterations in Their Stemness Features. | Tbeta4 | preclinical | 2021-03-31 |
| PRECLINICAL | evidence | Spatiotemporal single-cell RNA sequencing of developing chicken hearts identifies interplay between cellular differentiation and morphogenesis. | Thymosin beta 4 | — | 2021-03-19 |
| PRECLINICAL | evidence | Ectopic Expression of Human Thymosin beta4 Confers Resistance to Legionella pneumophila during Pulmonary and Systemic Infection in Mice. | Tbeta4 | Inflammation | 2021-03-17 |
| PRECLINICAL | evidence | Secondary Structures of Proteins: A Comparison of Models and Experimental Results. | Thymosin beta 4 | — | 2021-03-05 |
| PRECLINICAL | evidence | Amniotic fluid peptides predict postnatal kidney survival in developmental kidney disease. | Thymosin β4 | Kidney function | 2021-03-01 |
| PRECLINICAL | evidence | Multiple potential roles of thymosin beta4 in the growth and development of hair follicles. | Tbeta4 | — | 2021-02-01 |
| PRECLINICAL | evidence | Thymosin beta4 dynamics during chicken enteroid development. | Tbeta4 | — | 2021-02-01 |
| PRECLINICAL | evidence | Potential biomarkers of childhood brain tumor identified by proteomics of cerebrospinal fluid from extraventricular drainage (EVD). | Thymosin beta 4 | — | 2021-01-19 |
| PRECLINICAL | evidence | Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner. | Thymosin beta 4 | — | 2021-01-04 |
| PRECLINICAL | evidence | Solid-State, Thermal Synthesis of Peptide/Protein-Boron Cluster Conjugates. | Tbeta4 | — | 2021-01-01 |
| PRECLINICAL | evidence | Progress on the Function and Application of Thymosin beta4. | Tbeta4 | Inflammation | 2021-01-01 |
| PRECLINICAL | evidence | Corrigendum: Top-Down Proteomics of Human Saliva Highlights Anti-inflammatory, Antioxidant, and Antimicrobial Defense Responses in Alzheimer Disease. | Thymosin β4 | — | 2021-01-01 |